All Articles

A junior miner is drilling deep into BC, chasing a geological theory that could unearth the legendary hard rock source of historic placer gold.

A new partnership aims to fast-track a novel green hydrogen generator, unlocking autonomous power for remote industries and challenging fossil fuel logistics.

A high-grade silver discovery in a historic Idaho mining camp gets a strategic boost from significant antimony, a critical mineral vital for defense.

Enveric Biosciences heads to J.P. Morgan Week to pitch its novel non-hallucinogenic neuroplastogens. Can it secure the deals to disrupt mental health?

Uzbekistan's new Islamic Civilization Center has won a top prize, signaling a new era of cultural diplomacy and a revival of Golden Age science.

CIMG Inc. just won a "Most Investable" award, but a look under the hood reveals a company grappling with cash burn and a risky crypto strategy.

U.S. healthcare tech faces a talent crisis. The solution may lie in an unexpected place: a booming freelance market in Poland and Eastern Europe.

A surge in demand for an all-in-one dog walking kit reveals a deeper trend: how brands are using strategic design to win in the booming pet market.

A pivotal FDA meeting may have put Atossa Therapeutics' novel breast cancer drug, (Z)-endoxifen, on an accelerated path, a strategic win for investors.

For the seventh year, Greif tops a key responsibility list. We explore how the packaging giant turned ESG consistency into a powerful business advantage.

Camping World's latest dividend signals stability, but a deeper look reveals a complex strategy to navigate RV market headwinds and capitalize on new trends.

Beyond 200,000 houses, Meritage Homes' focus on energy efficiency and affordability is laying the foundational infrastructure for our connected future.

Volatus Aerospace appoints a top retired general, a strategic play to capture a share of Canada's multi-billion-dollar defense and NORAD modernization.

A novel drug aims to replace toxic chemo and conquer aggressive breast cancer. Can Intensity Therapeutics' direct tumor injection shift the treatment paradigm?

Reeling from a trial failure, Neuphoria Therapeutics battles an activist's lowball bid while its board scrambles to unlock hidden value in a high-stakes review.

An AWS award for Smarsh signals a seismic shift in financial compliance. Discover how AI and the cloud are rewriting the rules for risk management.

An Israeli biotech's manufacturing milestone isn't just a production win; it's a strategic move to commercialize its nasal shield technology.

Cambridge biotech Atavistik Bio reveals a novel allosteric inhibitor targeting a key MPN mutation, promising disease modification without current side effects.

A new survey finds social service workers optimistic about automation, but can technology truly fix a system plagued by staff shortages and policy hurdles?

As the EU rolls out its Digital Product Passport, the BSV Association is positioning its scalable blockchain as the key to unlocking supply chain trust.